Latigo Biotherapeutics, Inc. · NASDAQ:LTGO
5AM Partners VI, LLC converted 7,325,962 Latigo Biotherapeutics, Inc. shares (Form 4)
Traded Aug 10, 2026 · Filed Aug 12, 2026
On Aug 10, 2026, 5AM Partners VI, LLC (10% owner) converted 7,325,962 Latigo Biotherapeutics, Inc. shares, leaving 2,350,419 shares. Filed Aug 12, 2026 (Form 4).
- Converted
- 7,325,962 shares
- Holding after
- 2,350,419 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Common Stock | Conversion | 4,975,543 | 4,975,543 | Indirect | |
| Aug 10, 2026 | Common Stock | Conversion | 2,350,419 | 2,350,419 | Indirect |
Source
Related
- Latigo Biotherapeutics, Inc.
- 5AM Partners VI, LLC
- Latigo Biotherapeutics, Inc. shareholders
- Schedule 13G · AI Biotechnology LLC · Aug 18, 2026
- Schedule 13D · James B. Tananbaum · Aug 17, 2026
- Schedule 13G · Ra Capital Management, L.P. · Aug 17, 2026
- Schedule 13D · James B. Tananbaum · Aug 17, 2026
- Schedule 13G · Deep Track Capital, LP · Aug 13, 2026